In this week’s episode of “The Readout LOUD,” biotech veteran John Maraganore discusses his new startup, City Therapeutics, Nobel Prize awards, and his recent accolades. The podcast also explores why longevity-minded tech brokers are supporting controversial CRISPR scientist He Jiankui and his cryptocurrency financier. STAT’s Megan Molteni provides insights on this topic. Listeners can learn more about City Therapeutics, Nobel Prize-winning work in AI protein design, and purchase tickets for the upcoming STAT Summit in Boston. The episode is available on Apple Podcasts, Spotify, Stitcher, TuneIn, and other podcast platforms.
Source link
Crypto for CRISPR, a new RNAi startup, & a Nobel for AI
